Abstract
A novel series of (7-aryl-1,5-naphthyridin-2-yl)ureas was discovered as dual ERK2 and Aurora B kinases inhibitors. Several analogues were active at micromolar and submicromolar range against ERK2 and Aurora B, associated with very promising antiproliferative activity toward various cancer cell lines. Synthesis, structure activity relationship and docking study are reported. In vitro ADME properties and safety data are also discussed.
Keywords:
1,5-Naphthyridine; Antitumor activity; Aurora B; ERK2; Kinase inhibitor.
Copyright © 2014 Elsevier Ltd. All rights reserved.
MeSH terms
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Aurora Kinase B / antagonists & inhibitors*
-
Aurora Kinase B / metabolism
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Dose-Response Relationship, Drug
-
Drug Discovery*
-
Drug Screening Assays, Antitumor
-
HCT116 Cells
-
Humans
-
Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors*
-
Mitogen-Activated Protein Kinase 1 / metabolism
-
Models, Molecular
-
Molecular Structure
-
Protein Kinase Inhibitors / chemical synthesis
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / pharmacology*
-
Structure-Activity Relationship
-
Urea / analogs & derivatives
-
Urea / chemistry
-
Urea / pharmacology*
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Urea
-
Aurora Kinase B
-
Mitogen-Activated Protein Kinase 1